Neurodegeneration Flashcards
what are some of the main clinical features of Parkinson’s disease
tremor rigidity bradykinesia postural abnormality taste/smell disturbances difficulty with fine movement monotony of speech loss of balance depression
what is the pathogenesis of Parkinson’s
decreased pigmentation in substantia nigra (function of this pigment isn’t known) which leads to motor features of Parkinson’s
what is the biochemistry of Parkinson’s
reduction in caudate nucleus/putamen dopamine content
what are the classes of drugs used to treat Parkinson’s and name examples of drugs in these classes
L-DOPA - given with cabidopa which is a DOPA DDC so prevents it being converted into dopamine in the periphery (dopamine can’t cross BBB but L-DOPA can)
dopamine agonists - bromocriptine. acts on D2 receptors
MAOIs
COMT inhibitors - tolocapone, entacapone. improve delivery of L-DOPA across BBB
what are the drug classes used to treat Alzheimer’s and give examples
anti-cholinesterase only used in mild-moderate disease - stop working after 2 years donepezil rivastigmine galantamine
NMDA receptor blocker
memantine
what are the risk factors for Alzheimers
age
genetic predisposition - APP, PSEN, ApoE
what are the clinical symptoms of Alzheimers
memory loss disorientation/confusion language problems personality changes poor judgement
what is the Tau hypothesis for Alzheimers
tau proteins are soluble and in the microtubule of axons. The maintain the stability of microtubule complexes
Hyperphosphorylated tau is insoluble so it aggregates to form neurofibrillary tangles
These are neurotoxic and also result in microtubule instability
what is the amyloid hypothesis for Alzheimers
amyloid precursor protein (APP) is cleaved by beta secretase (should be cleaved by alpha- secretase) and is then cleaved by gamma-secretase
this produces beta amyloid protein which aggregates together and forms fibrils with are deposited on neuronal cells and form plaques
what is the inflammation hypothesis for Alzheimers
microglia become abnormal and their phenotype changes so that they attack normal neuronal cells
this is caused by increases in inflammatory mediators, increased phagocytosis of normal cells and decreased neuroprotective proteins